-
1
-
-
0032559775
-
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study
-
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593.
-
(1998)
Arch Intern Med.
, vol.158
, Issue.6
, pp. 585-593
-
-
Silverstein, M.D.1
Heit, J.A.2
Mohr, D.N.3
Petterson, T.M.4
O'Fallon, W.M.5
Melton, L.J.6
-
2
-
-
0026577798
-
The clinical course of pulmonary embolism
-
Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326(19):1240–1245.
-
(1992)
N Engl J Med.
, vol.326
, Issue.19
, pp. 1240-1245
-
-
Carson, J.L.1
Kelley, M.A.2
Duff, A.3
-
4
-
-
0033528247
-
Deep-vein thrombosis
-
Lensing AW, Prandoni P, Prins MH, Buller HR. Deep-vein thrombosis. Lancet. 1999;353(9151):479–485.
-
(1999)
Lancet.
, vol.353
, Issue.9151
, pp. 479-485
-
-
Lensing, A.W.1
Prandoni, P.2
Prins, M.H.3
Buller, H.R.4
-
5
-
-
78149254384
-
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
-
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450–2457.
-
(2010)
J Thromb Haemost.
, vol.8
, Issue.11
, pp. 2450-2457
-
-
Barbar, S.1
Noventa, F.2
Rossetto, V.3
-
6
-
-
84856809942
-
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e691S–e736S.
-
(2012)
Chest.
, vol.141
, Issue.2
, pp. e691S-e736S
-
-
Bates, S.M.1
Greer, I.A.2
Middeldorp, S.3
-
7
-
-
84884860407
-
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups
-
De Stefano V, Rossi E. Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost. 2013;110(4):697–705.
-
(2013)
Thromb Haemost.
, vol.110
, Issue.4
, pp. 697-705
-
-
De Stefano, V.1
Rossi, E.2
-
8
-
-
84856806342
-
Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e195S–e226S.
-
(2012)
Chest.
, vol.141
, Issue.2
, pp. e195S-e226S
-
-
Kahn, S.R.1
Lim, W.2
Dunn, A.S.3
-
9
-
-
67649160484
-
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review
-
Segal JB, Brotman DJ, Necochea AJ, et al. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA. 2009;301(23):2472–2485.
-
(2009)
JAMA.
, vol.301
, Issue.23
, pp. 2472-2485
-
-
Segal, J.B.1
Brotman, D.J.2
Necochea, A.J.3
-
12
-
-
0042658340
-
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
-
Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362(9383):523–526.
-
(2003)
Lancet.
, vol.362
, Issue.9383
, pp. 523-526
-
-
Baglin, T.1
Luddington, R.2
Brown, K.3
Baglin, C.4
-
13
-
-
58149393274
-
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
-
Kearon C, Julian JA, Kovacs MJ, et al. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 2008;112(12):4432–4436.
-
(2008)
Blood.
, vol.112
, Issue.12
, pp. 4432-4436
-
-
Kearon, C.1
Julian, J.A.2
Kovacs, M.J.3
-
14
-
-
34648847176
-
Testing for thrombophilia: an evidence-based approach
-
Merriman L, Greaves M. Testing for thrombophilia: an evidence-based approach. Postgrad Med J. 2006;82(973):699–704.
-
(2006)
Postgrad Med J.
, vol.82
, Issue.973
, pp. 699-704
-
-
Merriman, L.1
Greaves, M.2
-
15
-
-
18644369163
-
Thrombophilia, clinical factors, and recurrent venous thrombotic events
-
Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005;293(19):2352–2361.
-
(2005)
JAMA.
, vol.293
, Issue.19
, pp. 2352-2361
-
-
Christiansen, S.C.1
Cannegieter, S.C.2
Koster, T.3
Vandenbroucke, J.P.4
Rosendaal, F.R.5
-
16
-
-
33645729527
-
Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review
-
Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med. 2006;166(7):729–736.
-
(2006)
Arch Intern Med.
, vol.166
, Issue.7
, pp. 729-736
-
-
Ho, W.K.1
Hankey, G.J.2
Quinlan, D.J.3
Eikelboom, J.W.4
-
17
-
-
0022549729
-
Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states
-
Vigano D'Angelo S, Comp PC, Esmon CT, D'Angelo A. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest. 1986;77(2):416–425.
-
(1986)
J Clin Invest.
, vol.77
, Issue.2
, pp. 416-425
-
-
Vigano D'Angelo, S.1
Comp, P.C.2
Esmon, C.T.3
D'Angelo, A.4
-
18
-
-
55949104988
-
Inherited antithrombin deficiency: a review
-
Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia. 2008;14(6):1229–1239.
-
(2008)
Haemophilia.
, vol.14
, Issue.6
, pp. 1229-1239
-
-
Patnaik, M.M.1
Moll, S.2
-
19
-
-
0023090918
-
Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy
-
Weiss P, Soff GA, Halkin H, Seligsohn U. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res. 1987;45(6):783–790.
-
(1987)
Thromb Res.
, vol.45
, Issue.6
, pp. 783-790
-
-
Weiss, P.1
Soff, G.A.2
Halkin, H.3
Seligsohn, U.4
-
20
-
-
48549098855
-
Thrombophilia: common questions on laboratory assessment and management
-
Heit JA. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program. 2007:127–135.
-
(2007)
Hematology Am Soc Hematol Educ Program.
, pp. 127-135
-
-
Heit, J.A.1
-
21
-
-
84922393733
-
Activated protein C resistance testing for factor V Leiden
-
Kadauke S, Khor B, Van Cott EM. Activated protein C resistance testing for factor V Leiden. Am J Hematol. 2014;89(12):1147–1150.
-
(2014)
Am J Hematol.
, vol.89
, Issue.12
, pp. 1147-1150
-
-
Kadauke, S.1
Khor, B.2
Van Cott, E.M.3
-
22
-
-
0021715476
-
Quantitation of human protein S in the plasma of normal and warfarin-treated individuals by radioimmunoassay
-
Fair DS, Revak DJ. Quantitation of human protein S in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Thromb Res. 1984;36(6):527–535.
-
(1984)
Thromb Res.
, vol.36
, Issue.6
, pp. 527-535
-
-
Fair, D.S.1
Revak, D.J.2
-
23
-
-
1842788215
-
Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice
-
Bank I, Scavenius MP, Buller HR, Middeldorp S. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res. 2004;113(1):7–12.
-
(2004)
Thromb Res.
, vol.113
, Issue.1
, pp. 7-12
-
-
Bank, I.1
Scavenius, M.P.2
Buller, H.R.3
Middeldorp, S.4
-
24
-
-
0035489312
-
Hypercoagulability: clinical assessment and treatment
-
Abramson N, Abramson S. Hypercoagulability: clinical assessment and treatment. South Med J. 2001;94(10):1013–1020.
-
(2001)
South Med J.
, vol.94
, Issue.10
, pp. 1013-1020
-
-
Abramson, N.1
Abramson, S.2
-
25
-
-
33745788144
-
An evaluation of thrombophilia screening in an urban tertiary care medical center: A “real world” experience
-
Somma J, Sussman, II, Rand JH. An evaluation of thrombophilia screening in an urban tertiary care medical center: A “real world” experience. Am J Clin Pathol. 2006;126(1):120–127.
-
(2006)
Am J Clin Pathol.
, vol.126
, Issue.1
, pp. 120-127
-
-
Somma, J.1
Sussman, I.I.2
Rand, J.H.3
-
26
-
-
84992461048
-
-
Accessed January 18
-
CodeMap. Available at: https://www.codemap.com. Accessed January 18, 2016.
-
(2016)
CodeMap
-
-
-
27
-
-
78751633462
-
Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members
-
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med. 2011;13(1):67–76.
-
(2011)
Genet Med.
, vol.13
, Issue.1
, pp. 67-76
-
-
-
28
-
-
0034676551
-
Safety of withholding heparin in pregnant women with a history of venous thromboembolism
-
Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000;343(20):1439–1444.
-
(2000)
N Engl J Med.
, vol.343
, Issue.20
, pp. 1439-1444
-
-
Brill-Edwards, P.1
Ginsberg, J.S.2
Gent, M.3
-
29
-
-
12644301204
-
Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis
-
Friederich PW, Sanson BJ, Simioni P, et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med. 1996;125(12):955–960.
-
(1996)
Ann Intern Med.
, vol.125
, Issue.12
, pp. 955-960
-
-
Friederich, P.W.1
Sanson, B.J.2
Simioni, P.3
-
30
-
-
84863600745
-
Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance
-
Chong LY, Fenu E, Stansby G, Hodgkinson S; Guideline Development Group. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. BMJ. 2012;344:e3979.
-
(2012)
BMJ.
, vol.344
-
-
Chong, L.Y.1
Fenu, E.2
Stansby, G.3
Hodgkinson, S.4
-
31
-
-
84903820473
-
-
Choosing Wisely website., Published December 4, 2013. Accessed January 18
-
American Society of Hematology. Ten things physicians and patients should question. Choosing Wisely website. Available at: http://www.choosingwisely.org/societies/american-society-of-hematology. Published December 4, 2013. Accessed January 18, 2016.
-
(2016)
Ten things physicians and patients should question
-
-
-
32
-
-
84992459468
-
-
Choosing Wisely website., Published July 10, 2015. Accessed March 13
-
American College of Medical Genetics and Genomics. Five Things patients and providers should question. Choosing Wisely website. Available at: http://www.choosingwisely.org/societies/american-college-of-medical-genetics-and-genomics. Published July 10, 2015. Accessed March 13, 2016.
-
(2016)
Five Things patients and providers should question
-
-
|